Ashish Sharma, MD, on what real-world data show about switching and long-term outcomes with retinal biosimilars.
Ashish Sharma, MD
Advertisement
Ashish Sharma, MD, is founder and chair, International Retina Biosimilar Study Group (Inter-BIOS), and consultant retina and director of clinical research at the Lotus Eye Hospital and Institute in Coimbatore, India.
Articles by Ashish Sharma, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
EURETINA 2026: nAMD imaging biomarkers and real-world switch outcomes
2
EURETINA 2026: Women’s health and pregnancy in the spotlight
3
EURETINA 2026: OCT biomarkers that predict, preempt and pinpoint retinal disease
4
EURETINA 2026: Why half-dose PDT leads the treatment of central serous chorioretinopathy
5